Intangible Assets and Goodwill

6 Months Ended

Jul. 03, 2011

Intangible Assets and Goodwill [Abstract]

NOTE 3 — INTANGIBLE ASSETS AND GOODWILL

Intangible assets that have finite useful lives are amortized over their estimated useful lives. The latest impairment assessment of goodwill and indefinite lived intangible assets was completed in the fiscal fourth quarter of 2010. Future impairment tests for goodwill and indefinite lived intangible assets will be performed annually in the fiscal fourth quarter, or sooner if warranted.


	July 3,		January 2,
(Dollars in Millions)	2011		2011
Intangible assets with definite lives:
Patents and trademarks — gross	$	7,520		6,660
Less accumulated amortization		2,819		2,629
Patents and trademarks — net		4,701		4,031

Other intangibles — gross		8,609		7,674
Less accumulated amortization		3,048		2,880
Other intangibles — net		5,561		4,794

Intangible assets with indefinite lives:
Trademarks		6,080		5,954
Purchased in-process research and development		2,036		1,937
Total intangible assets with indefinite lives		8,116		7,891

Total intangible assets — net	$	18,378		16,716

During the fiscal second quarter of 2011, the Company reclassified $971 million from purchased in-process research and development to amortizable other intangibles to reflect the commercialization of ZYTIGA®.

Goodwill as of July 3, 2011 was allocated by segment of business as follows:


					Med Dev
(Dollars in Millions)	Consumer		Pharm		& Diag		Total
Goodwill, net at January 2, 2011	$	8,144		1,225		5,925		15,294
Acquisitions		—		538		—		538
Currency translation/Other		320		52		39		411
Goodwill, net as of July 3, 2011	$	8,464		1,815		5,964		16,243

The weighted average amortization periods for patents and trademarks and other intangible assets are 17 years and 27 years, respectively. The amortization expense of amortizable intangible assets for the fiscal six months ended July 3, 2011 was $402 million, and the estimated amortization expense for the five succeeding years approximates $840 million, per year.

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References+ Details